Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Graft vasculopathy in clinical hand transplantation.

Kaufman CL, Ouseph R, Blair B, Kutz JE, Tsai TM, Scheker LR, Tien HY, Moreno R, Ozyurekoglu T, Banegas R, Murphy E, Burns CB, Zaring R, Cook DF, Marvin MR.

Am J Transplant. 2012 Apr;12(4):1004-16. doi: 10.1111/j.1600-6143.2011.03915.x.

2.

Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts.

Kanitakis J, Karayannopoulou G, Lanzetta M, Petruzzo P.

Transpl Int. 2014 Nov;27(11):e118-23. doi: 10.1111/tri.12399.

3.

Capillary Thrombosis in the Skin: A Pathologic Hallmark of Severe/Chronic Rejection of Human Vascularized Composite Tissue Allografts?

Kanitakis J, Petruzzo P, Gazarian A, Karayannopoulou G, Buron F, Dubois V, Thaunat O, Badet L, Morelon E.

Transplantation. 2016 Apr;100(4):954-7. doi: 10.1097/TP.0000000000000882.

PMID:
27003099
4.

Chronic rejection in vascularized composite allografts.

Mundinger GS, Drachenberg CB.

Curr Opin Organ Transplant. 2014 Jun;19(3):309-14. doi: 10.1097/MOT.0000000000000073. Review.

PMID:
24811439
5.

Notable features in composite tissue allografts: value of high-resolution ultrasonography as a first-line imaging modality.

Ostermann S, Loizides A, Spiss V, Peer S, Gruber H.

Ultraschall Med. 2011 Dec;32 Suppl 2:E1-7. doi: 10.1055/s-0031-1281678.

PMID:
22179804
6.

Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation.

Mundinger GS, Munivenkatappa R, Drachenberg CB, Ha JS, Vaca EE, Shipley ST, Papadimitriou JC, Bartlett ST, Rodriguez ED, Barth RN.

Transplantation. 2013 May 27;95(10):1204-10. doi: 10.1097/TP.0b013e31828d1528.

PMID:
23694932
7.

Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome.

Yamani MH, Haji SA, Starling RC, Tuzcu EM, Ratliff NB, Cook DJ, Abdo A, Crowe T, Secic M, McCarthy P, Young JB.

J Am Coll Cardiol. 2002 Mar 20;39(6):970-7.

8.

Pathologic characteristics of early or late acute cellular rejection and outcome after kidney transplant.

Wu K, Budde K, Schmidt D, Neumayer HH, Rudolph B.

Exp Clin Transplant. 2014 Aug;12(4):314-22.

9.

Is Duplex-Ultrasound a useful tool in defining rejection episodes in composite tissue allograft transplants?

Loizides A, Kronberger IE, Plaikner M, Gruber H.

Med Ultrason. 2015 Dec;17(4):550-2. doi: 10.11152/mu.2013.2066.174.dxu.

10.

Chronic rejection with or without transplant vasculopathy.

Sijpkens YW, Doxiadis II, van Kemenade FJ, Zwinderman AH, de Fijter JW, Claas FH, Bruijn JA, Paul LC.

Clin Transplant. 2003 Jun;17(3):163-70.

PMID:
12780663
11.

Allograft vasculopathy after allogeneic vascularized knee transplantation.

Diefenbeck M, Nerlich A, Schneeberger S, Wagner F, Hofmann GO.

Transpl Int. 2011 Jan;24(1):e1-5. doi: 10.1111/j.1432-2277.2010.01178.x.

12.

Transplant vasculopathy in early protocol renal allograft biopsies.

Serón D, Moreso F.

Transplant Proc. 1999 Sep;31(6):2219-20. No abstract available.

PMID:
10500552
13.

Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study.

Jimenez J, Kapadia SR, Yamani MH, Platt L, Hobbs RE, Rincon G, Botts-Silverman C, Starling RC, Young JB, Nissen SE, Tuzcu M, Ratliff NB.

J Heart Lung Transplant. 2001 Apr;20(4):393-8. Erratum in: J Heart Lung Transplant 2001 Jul;20(7):803.

PMID:
11295576
14.

The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.

Arora S, Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Sigurdardottir V, Dellgren G, Erikstad I, Solberg OG, Ueland T, Aukrust P, Gullestad L; SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators..

Am J Transplant. 2015 Jul;15(7):1967-75. doi: 10.1111/ajt.13214.

15.

A single center experience of abdominal wall graft rejection after combined intestinal and abdominal wall transplantation.

Allin BS, Ceresa CD, Issa F, Casey G, Espinoza O, Reddy S, Sinha S, Giele H, Friend P, Vaidya A.

Am J Transplant. 2013 Aug;13(8):2211-5. doi: 10.1111/ajt.12337.

16.

[Hand transplantation - fiction or reality?].

Vögelin E.

Ther Umsch. 2011 Dec;68(12):730-4. doi: 10.1024/0040-5930/a000237. Review. German.

PMID:
22139989
17.

Standardizing skin biopsy sampling to assess rejection in vascularized composite allotransplantation.

Hautz T, Zelger BG, Weissenbacher A, Zelger B, Brandacher G, Landin L, Morelon E, Kanitakis J, Jablecki J, Lee WP, Pratschke J, Schneeberger S.

Clin Transplant. 2013 Mar-Apr;27(2):E81-90. doi: 10.1111/ctr.12086. Review.

PMID:
23452279
18.

ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiences.

Stock KF, Klein BS, Cong MT, Regenbogen C, Kemmner S, Büttner M, Wagenpfeil S, Matevossian E, Renders L, Heemann U, Küchle C.

Clin Hemorheol Microcirc. 2011;49(1-4):527-35. doi: 10.3233/CH-2011-1503.

PMID:
22214724
19.

C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.

Luk A, Alba AC, Butany J, Tinckam K, Delgado D, Ross HJ.

Transpl Int. 2015 Jul;28(7):857-63. doi: 10.1111/tri.12560.

20.

Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts.

Hautz T, Zelger BG, Nasr IW, Mundinger GS, Barth RN, Rodriguez ED, Brandacher G, Weissenbacher A, Zelger B, Cavadas P, Margreiter R, Lee WP, Pratschke J, Lakkis FG, Schneeberger S.

Transpl Int. 2014 Sep;27(9):966-76. doi: 10.1111/tri.12358.

Supplemental Content

Support Center